Literature DB >> 22830411

Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.

Dawn C Buse1, Aubrey N Manack, Kristina M Fanning, Daniel Serrano, Michael L Reed, Catherine C Turkel, Richard B Lipton.   

Abstract

OBJECTIVES: To estimate the prevalence and distribution of chronic migraine (CM) in the US population and compare the age- and sex-specific profiles of headache-related disability in persons with CM and episodic migraine.
BACKGROUND: Global estimates of CM prevalence using various definitions typically range from 1.4% to 2.2%, but the influence of sociodemographic factors has not been completely characterized.
METHODS: The American Migraine Prevalence and Prevention Study mailed surveys to a sample of 120,000 US households selected to represent the US population. Data on headache frequency, symptoms, sociodemographics, and headache-related disability (using the Migraine Disability Assessment Scale) were obtained. Modified Silberstein-Lipton criteria were used to classify CM (meeting International Classification of Headache Disorders, second edition, criteria for migraine with a headache frequency of ≥15 days over the preceding 3 months).
RESULTS: Surveys were returned by 162,756 individuals aged ≥12 years; 19,189 individuals (11.79%) met International Classification of Headache Disorders, second edition, criteria for migraine (17.27% of females; 5.72% of males), and 0.91% met criteria for CM (1.29% of females; 0.48% of males). Relative to 12 to 17 year olds, the age- and sex-specific prevalence for CM peaked in the 40s at 1.89% (prevalence ratio 4.57; 95% confidence interval 3.13-6.67) for females and 0.79% (prevalence ratio 3.35; 95% confidence interval 1.99-5.63) for males. In univariate and adjusted models, CM prevalence was inversely related to annual household income. Lower income groups had higher rates of CM. Individuals with CM had greater headache-related disability than those with episodic migraine and were more likely to be in the highest Migraine Disability Assessment Scale grade (37.96% vs. 9.50%, respectively). Headache-related disability was highest among females with CM compared with males. CM represented 7.68% of migraine cases overall, and the proportion generally increased with age.
CONCLUSIONS: In the US population, the prevalence of CM was nearly 1%. In adjusted models, CM prevalence was highest among females, in mid-life, and in households with the lowest annual income. Severe headache-related disability was more common among persons with CM and most common among females with CM.
© 2012 American Headache Society.

Entities:  

Keywords:  chronic migraine; episodic migraine; headache-related disability; prevalence; sociodemographics

Mesh:

Year:  2012        PMID: 22830411     DOI: 10.1111/j.1526-4610.2012.02223.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  118 in total

1.  Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study.

Authors:  Maria Michela Cainazzo; Carlo Baraldi; Anna Ferrari; Flavia Lo Castro; Luca Pani; Simona Guerzoni
Journal:  Neurol Sci       Date:  2021-02-05       Impact factor: 3.307

2.  Fibromyalgia comorbidity in a community sample of adults with migraine.

Authors:  Dawn A Marcus; Amrita Bhowmick
Journal:  Clin Rheumatol       Date:  2013-06-07       Impact factor: 2.980

3.  Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders.

Authors:  Gülşen Kocaman; Neşe Kahraman; Banu Gürkan Köseoğlu; Başar Bilgiç; Zeliha Matur; Mustafa Ertaş; Yeşim Gülşen; Betül Baykan Baykal
Journal:  Noro Psikiyatr Ars       Date:  2018-07-06       Impact factor: 1.339

Review 4.  Chronic daily headache in the elderly.

Authors:  Aynur Özge
Journal:  Curr Pain Headache Rep       Date:  2013-12

5.  Do bilateral and unilateral greater occipital nerve block effectiveness differ in chronic migraine patients?

Authors:  Hanzade Aybüke Ünal-Artık; Levent Ertuğrul İnan; Ceyla Ataç-Uçar; Tahir Kurtuluş Yoldaş
Journal:  Neurol Sci       Date:  2017-02-28       Impact factor: 3.307

Review 6.  Approach to chronic daily headache.

Authors:  Huma U Sheikh
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

7.  Treatment of PTSD and Chronic Daily Headache.

Authors:  Todd A Smitherman; Anna Katherine Black; Christal N Davis
Journal:  Curr Treat Options Neurol       Date:  2014-10       Impact factor: 3.598

8.  Predictors of Prolonged Hospital Stay in Status Migrainosus.

Authors:  S Y Modi; D Dharaiya; A M Katramados; P Mitsias
Journal:  Neurohospitalist       Date:  2016-04-05

Review 9.  Headache in Behçet's syndrome: review of literature and NYU Behçet's syndrome center experience.

Authors:  Vijay Vishwanath; Ericka Wong; Sara C Crystal; Matthew S Robbins; Maria Filopoulos; Richard B Lipton; Yusuf Yazici; Ilya Kister
Journal:  Curr Pain Headache Rep       Date:  2014-09

10.  Hypertension and Migraine in the Northern Manhattan Study.

Authors:  Hannah Gardener; Teshamae Monteith; Tatjana Rundek; Clinton B Wright; Mitchell S V Elkind; Ralph L Sacco
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.